Table 4.
Clinical characteristics of the case group at the time of enrollment
| Case ID | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 |
|---|---|---|---|---|---|---|---|---|---|
| Parameter | |||||||||
| Age (Y) | 47 | 70 | 69 | 43 | 69 | 63 | 44 | 44 | 52 |
| Sex (M/F) | F | F | M | F | M | F | F | F | M |
| ESRD duration (month) | 217 | 96 | 36 | 278 | 121 | 121 | 124 | 68 | 66 |
| PD duration (month) | 81 | 96 | 36 | 25 | 121 | 121 | 124 | 24 | 66 |
| DM | No | No | Yes | No | No | Yes | Yes | Yes | No |
| HTN | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes |
| Cause of ESRD | Unknown | PKD | HTN | Rec.UTI | HTN | DM | Unknown | DM | HTN |
| Weight (kg) | 43 | 63 | 73 | 67 | 66 | 63 | 85 | 81 | 64 |
| BMI (kg/m2) | 19.1 | 24.6 | 27.8 | 26.2 | 21.6 | 27.3 | 36.3 | 33.7 | 25.6 |
| SBP (mmHg) | 120 | 110 | 130 | 110 | 120 | 140 | 130 | 130 | 170 |
| DBP (mmHg) | 65 | 70 | 80 | 70 | 80 | 80 | 90 | 80 | 110 |
| Anuria (yes/no) | Yes | Yes | No | Yes | No | No | Yes | Yes | Yes |
| Overnight fluid | Ico | Ico | 4.25% Dextrose | Ico | Ico | 4.25% Dextrose | Ico | Ico | Ico |
| Transport type | H | H | HA | HA | HA | H | HA | HA | HA |
| 24 hours UF (ml) | 1300 | 1600 | 800 | 850 | 1200 | 300 | 2000 | 2000 | 900 |
| GFR (ml/minutes/1.73 m2) | 0 | 0 | 3.55 | 0 | 2.94 | 1.58 | 0 | 0 | 0 |
| D/P cr | 0.93 | 0.85 | 0.76 | 0.69 | 0.74 | 0.88 | 0.74 | 0.69 | 0.7 |
| N of exchange/24 hours | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 4 |
| No of cell/kg | 1, 155, 555.6 | 1, 269, 841.3 | 1, 066, 666.7 | 1, 290, 322.6 | 1, 363, 636.4 | 1, 269, 841.3 | 941, 176.5 | 1, 117, 647.1 | 1, 250, 000.0 |
| Medication | Eprex (4000 unit/3 week), calcium carbonate, nephrovite | Erythropoietin, nephrovite, ASA (80 mg), atorvastatin (40 mg/day), losartan (50 mg/BID) | Eprex (4000 unit/8 week), calcium carbonate, folic acid, ASA (80 mg), captopril (50 mg/day), losartan (25 mg/BID), amlodipine (5 mg/day), furosemide (60 mg/TID), atorvastatin (20 mg/day), allopurinol (100 mg/day), insulin | Erythropoietin, calcium carbonate, Rocaltrol, | Erythropoietin, calcium carbonate, folic acid, B complex, renagel (8 mg/day), furosemide (40 mg/BID), Allopurinol (100 mg/day) | Erythropoietin, nephrovite, calcium carbonate, rocaltrol, vitamin c, carnitine, spironolactone (50 mg/day), furosemide (80 mg/BID) | Erythropoietin, calcium carbonate, rocaltrol, folic acid, vitamin c, losartan (50 mg/BID), atorvastatin (20 mg/BID), insulin | Erythropoietin, calcium carbonate, rocaltrol, vitamin D, ASA (80 mg), allopurinol (100 mg/day), losartan (50 mg/ BID), metoral (100 mg/day), spironolactone (50 mg/day), insulin | Erythropoietin, calcium carbonate, vitamin D, ASA (80 mg), folic acid, Amlodipin (5 mg/BID), valsacor (160 mg/BID), spironolactone (25 mg/day) |
ESRD; End-stage renal disease, Rec, UTI; Recurrent urinary tract infection, PD; Peritoneal dialysis, DM; Diabetes mellitus, HTN; Hypertension, BMI; BodyMass Index, SBP; Systolic blood pressure, DBP; Diastolic blood pressure, UF; Ultrafiltration, Ico; Icodextrin, PKD; Polycystic kidney disease, F; Female, M; Male, GFR; Glomerular filtration rate, D/P cr; Dialysate to plasma ratio of creatinin, H; High, and HA; High average.